Antibiotics for treating osteomyelitis in people with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Martí Carvajal, Arturo ^a   Agreda Perez L ^b   Cortes Jofre M ^b  

^a Centro Colaborador Venezolano de la Red Cochrane Iberoamericana   (Venezuela)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; OSTEOMYELITIS; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA;

EID: 44949200179     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007175     Document Type: Review

References (41)

1. Bahebeck 2004 Bahebeck J, Atangana R, Techa A, Monny-Lobe M, Sosso M, Hoffmeyer P. Relative rates and features of musculoskeletal complications in adult sicklers. Acta Orthopaedica Belgica 2004;70(2):107-11.
2. Begue 2001 Begue P, Castello-Herbreteau B. Severe infections in children with sickle cell disease: clinical aspects and prevention. Archives de Pédiatrie 2001;8(Suppl 4):732s-41s.
3. Bennet 2006 Bennet GC, Bennet SJ. Infection of bone and joint. Surgery 2006;24(6):211-4.
4. Bunn 1997 Bunn HF. Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine 1997;337(11):762-9.
5. Burnett 1998 Burnett MW, Bass JW, Cook BA. Etiology of osteomyelitis complicating sickle cell disease. Pediatrics 1998;101(2):296-7.
6. Carek 2001 Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. American Family Physician 2001;63(12):2413-20.
7. Ciampolini 2000 Ciampolini J, Harding KG. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?. Postgraduate Medical Journal 2000;76(898):479-83.
8. Epps 1991 Epps CH Jr, Bryant DD 3rd, Coles MJ, Castro O. Osteomyelitis in patients who have sickle-cell disease. Diagnosis and management. Journal of Bone and Joint Surgery 1991;73(9):1281-94.
9. Hebbel 2004 Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004;11(2):129-51.
10. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
11. Higgins 2005a Higgins JPT, Green S, editors. Analysing and Presenting Results. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8. The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons; Ltd 2005, Issue 3.
12. Higgins 2005b Higgins JPT, Green S, editors. Assessment of Study Quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 6. The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd 2005; Issue 3 2005.
13. Ibingira 2003 Ibingira CB. Chronic osteomyelitis in a Ugandan rural setting. East African Medical Journal 2003;80(5):242-6.
14. Jüni 2001 Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
15. Kim 2002 Kim SK, Miller JH. Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. Journal of Nuclear Medicine 2002;43(7):896-900.
16. Lazzarini 2005 Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?. International Journal of Infectious Diseases 2005;9(3):127-38.
17. Le Saux 2002 Le Saux N, Howard A, Barrowman NJ, Gaboury I, Sampson M, Moher D. Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review. BMC Infectious Diseases 2002;14(2):16.
18. Lew 2004 Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364(9431):369-79.
19. Mansingh 2003 Mansingh A, Ware M. Acute haematogenous anaerobic osteomyelitis in sickle cell disease. A case report and review of the literature. West Indian Medical Journal 2003;52(1):53-5.
20. Meddeb 2003 Meddeb N, Gandoura N, Gandoura M, Sellami S. Osteoarticular manifestations of sickle cell disease. La Tunisie Médicale 2003;81(7):441-7.
21. Neonato 2000 Neonato MG, Guilloud-Bataille M, Beauvais P, Begue P, Belloy M, Benkerrou M, et al.Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. European Journal of Haematology 2000;65(3):155-64.
22. Nwadiaro 2000 Nwadiaro HC, Ugwu BT, Legbo JN. Chronic osteomyelitis in patients with sickle cell disease. East African Medical Journal 2000;77(1):23-6.
23. Onche 2004 Onche II, Obiano SK. Chronic osteomyelitis of long bones: reasons for delay in presentation. Nigerian Journal of Medicine 2004;13(4):355-8.
24. Paluska 2004 Paluska SA. Osteomyelitis. Clinics in Family Practice 2004;6(1):127-56.
25. Pauling 1949 Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110:543-6.
26. RevMan 2005 The Cochrane Collaboration, 2005. Review Manager (RevMan). Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2005., 2005.
27. Sadat-Ali 1998 Sadat-Ali M. The status of acute osteomyelitis in sickle cell disease. A 15-year review. International Surgery 1998;83(1):84-7.
28. Sathappan 2006 Sathappan SS, Ginat D, Di Cesare PE. Multidisciplinary management of orthopedic patients with sickle cell disease. Orthopedics 2006;29(12):1094-101.
29. Saunthararajah 2004 Saunthararajah Y, Vichinsky EP, Embury SH. Sickle cell disease. Hoffman: Hematology: Basic Principles and Practice. Churchill Livingstone, 2004.
30. Serjeant 1992 Serjeant GR. Sickle Cell Disease. New York: Oxford Medical Publications, 1992.
31. Serjeant 2001 Serjeant GR. The emerging understanding of sickle cell disease. British Journal of Haematology 2001;112(1):3-18.
32. Sia 2006 Sia IG, Berbari EF. Infection and musculoskeletal conditions: Osteomyelitis. Baillière's Best Practice & Research. Clinical Rheumatology 2006;20(6):1065-81.
33. Skaggs 2001 Skaggs DL, Kim SK, Greene NW, Harris D, Miller JH. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. The Journal of Bone and Joint Surgery. American volume 2001;83-A(12):1810-3.
34. Steinberg 2006 Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends in Pharmacological Sciences 2006;27(4):204-10.
35. Stuart 2004 Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364(9442):1343-60.
36. Tarer 2006 Tarer V, Etienne-Julan M, Diara JP, Belloy MS, Mukizi-Mukaza M, Elion J, et al.Sickle cell anemia in Guadeloupean children: pattern and prevalence of acute clinical events. European Journal of Haematology 2006;76(3):193-9.
37. Tekou 2000 Tekou H, Foly A, Akue B. Current profile of hematogenous osteomyelitis in children at the Tokoin University Hospital Center in Lome, Togo. Report of 145 cases. Médecine tropicale: revue du Corps de santé colonial 2000;60(4):365-8.
38. Thanni 2006 Thanni LO. Bacterial osteomyelitis in major sickling haemoglobinopathies: geographic difference in pathogen prevalence. African Health Sciences 2006;6(4):236-9.
39. Weatherall 2006 Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited Disorders of Hemoglobin. Disease Control Priorities in Developing Countries. 2nd Edition. Washington DC: The World Bank and Oxford University Press, 2006.
40. William 2007 William BM, Corazza GR. Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology 2007;12(2):1-13.
41. Witjes 2006 Witjes MJ, Berghuis-Bergsma N, Phan TT. Positron emission tomography scans for distinguishing between osteomyelitis and infarction in sickle cell disease. British Journal of Haematology 2006;133(2):212-4.